1st Counsel – Lifestyle
Author:
Pramana Pharmaceuticals Inc.
Diginex Limited (DGNX) Announces US$1.5 Billion AI Acquisition, Adding High Growth Business and Targets $280M Revenue by 2027
April 17, 2026
Diginex Appoints Chief Operating Officer and Chief Administrative Officer to Accelerate Implementation of Business Strategy
April 2, 2026
Diginex Sets New Strategic Course to Become the Global Benchmark for Institutional Integrity
March 31, 2026
Diginex Limited Announces Extraordinary General Meeting to Approve Share Capital Increase and Share Consolidation
March 30, 2026
Architect of Modern Diabetes Medicine Dr. Ralph A. DeFronzo Joins Pramana Pharmaceuticals as Chief Medical Advisor
March 24, 2026